The Fragility Index of Randomized Controlled Trials for Preterm Neonates
BackgroundAs a metric to determine the robustness of trial results, the fragility index (FI) is the number indicating how many patients would be required to reverse the significant results. This study aimed to calculate the FI in randomized controlled trials (RCTs) involving premature.MethodsTrials...
Saved in:
Main Authors: | Huiyi Li (Author), Zhenyu Liang (Author), Qiong Meng (Author), Xin Huang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How fragile the positive results of Chinese herbal medicine randomized controlled trials on irritable bowel syndrome are?
by: Minjing Luo, et al.
Published: (2024) -
Effects of antenatal corticosteroids in twin neonates with late preterm birth (ACTWIN [Antenatal Corticosteroids in TWIN late preterm neonates] trial): study protocol for a randomized controlled trial
by: Subeen Hong, et al.
Published: (2019) -
Skin-to-Skin Care by Mother vs. Father for Preterm Neonatal Pain: A Randomized Control Trial (ENVIRON Trial)
by: Vivek Vishwanath Shukla, et al.
Published: (2021) -
The effect of the 'M' Technique® massage on physiological parameters in preterm neonates: a randomized controlled trial study
by: Mona Alinejad-Naeini, et al.
Published: (2022) -
Melatonin as an adjuvant therapy in preterm infants with neonatal sepsis, randomized trial
by: Zeinab A. El-Kabbany, et al.
Published: (2020)